In addition, recent studies had demonstrated that other clinical parameters, like lymphocyte-to-monocyte ratio, serum albumin, and C-reactive protein, have the robust prognostic values in DLBCL patients (8–10). Here, ALB is linked to diffuse large B-cell lymphoma.